Gai Ayalon
Ultragenyx Pharmaceutical (United States)(US)
Publications by Year
Research Areas
Alzheimer's disease research and treatments, Neuroscience and Neuropharmacology Research, Dementia and Cognitive Impairment Research, Muscle Physiology and Disorders, Neuroinflammation and Neurodegeneration Mechanisms
Most-Cited Works
- → A meta-analysis of genome-wide association studies identifies 17 new Parkinson's disease risk loci(2017)1,197 cited
- → Diverse Brain Myeloid Expression Profiles Reveal Distinct Microglial Activation States and Aspects of Alzheimer’s Disease Not Evident in Mouse Models(2018)694 cited
- → Stargazin Reduces Desensitization and Slows Deactivation of the AMPA-Type Glutamate Receptors(2005)249 cited
- → Functional Assembly of AMPA and Kainate Receptors Is Mediated by Several Discrete Protein-Protein Interactions(2001)247 cited
- → An Ankyrin-Based Mechanism for Functional Organization of Dystrophin and Dystroglycan(2008)140 cited
- → Antibody-Mediated Targeting of Tau In Vivo Does Not Require Effector Function and Microglial Engagement(2016)131 cited
- → [18F]GTP1 (Genentech Tau Probe 1), a radioligand for detecting neurofibrillary tangle tau pathology in Alzheimer’s disease(2019)128 cited
- → Antibody semorinemab reduces tau pathology in a transgenic mouse model and engages tau in patients with Alzheimer’s disease(2021)106 cited
- → Dual leucine zipper kinase is required for excitotoxicity-induced neuronal degeneration(2013)105 cited
- → Predictors of cognitive impairment in primary age-related tauopathy: an autopsy study(2021)86 cited